Edition:
India

Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

1,893.95INR
19 Oct 2018
Change (% chg)

Rs-204.80 (-9.76%)
Prev Close
Rs2,098.75
Open
Rs2,090.00
Day's High
Rs2,133.80
Day's Low
Rs1,852.65
Volume
1,950,199
Avg. Vol
494,055
52-wk High
Rs3,307.95
52-wk Low
Rs1,852.65

Chart for

About

Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries. The Company's pharmaceutical business consists of manufacturing and sale of own and traded bulk drugs and formulations. It operates through... (more)

Overall

Beta: 0.59
Market Cap(Mil.): Rs466,533.00
Shares Outstanding(Mil.): 172.56
Dividend: 21.00
Yield (%): 0.78

Financials

  PIRA.NS Industry Sector
P/E (TTM): 35.23 30.90 33.64
EPS (TTM): 76.73 -- --
ROI: -- 14.75 14.27
ROE: -- 16.24 15.99

CARE ratings for Indian debt instruments-Sep 17

Sep 17 Below are the ratings awarded by Credit Analysis and Research Ltd. (CARE) for local debt instruments as of September 14, 2018. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------- ---------- ------ ------- --------- SHORT TERM RATINGS: ------------------- Adroit Pharmaceuticals Pvt Ltd ST Bk Fac

17 Sep 2018

MEDIA-Piramal Enterprises may re-enter Indian drug market - Mint

- Note: Reuters has not verified this story and does not vouch for its accuracy

29 May 2018

Earnings vs. Estimates